Therefore, we have identified a signature consisting of four genes associated with neurotransmitter receptors: CHRNA3, GABRD, GRIK3, and GRIK5 to predict prognosis and treatment response in CRC patients. This evidence concerns the gene GABRD and colorectal carcinoma.